Download the free e-book on peptides, hormones and pharmaceuticals for longevity, health and performance here: get the e-book
Whether you’re tracking your health or preparing to optimize, our 60+ biomarker comprehensive bloodowrk panel covers hormones, thyroid, metabolic function, inflammation, and more for $99. No consultation required. Order here.
Almost everyone who loses a meaningful amount of weight reaches a point where the scale stops moving. Intake has not changed. Training has not changed. Effort has, if anything, gone up. And the number stays flat for weeks.
The usual advice is to eat less and move more, which treats a plateau as a failure of discipline. The biology says otherwise. A plateau is the predictable result of a body defending its weight, and some plateaus are not plateaus at all. Knowing which one you are dealing with changes what you should do next.
Is it a real plateau?
Scale weight is a noisy measurement. Day to day it moves with water, sodium, glycogen, digestive contents, hormonal cycles, and stress. A person can lose a pound of fat and gain two pounds of water in the same week, particularly after a hard training block, a high sodium meal, or a stressful stretch.
A working rule is that a true plateau means two to four weeks of flat weekly averages, not a few flat days. Comparing weekly averages instead of daily weigh-ins removes much of the noise.
Even then, the scale cannot say what is changing. Someone gaining muscle while losing fat can hold the same weight for months while body composition improves. This is the case for measuring composition directly. DEXA separates fat mass, lean mass, and visceral fat, so a stalled scale can be read correctly: either fat is still coming off while lean mass rises, or fat loss has genuinely stopped.
Metabolic adaptation
When body weight falls, total energy expenditure falls with it, because there is less tissue to maintain and less mass to move. That drop is expected. What surprises people is that expenditure often falls by more than the smaller body size predicts. This extra reduction is called adaptive thermogenesis, a protective response in which the body lowers energy use to defend its stored fuel.
Follow-up studies of people who lost large amounts of weight through intensive programs found that resting metabolic rate stayed meaningfully below what their new body size predicted, even years later. The size of the effect varies widely between individuals and is still debated, but the direction is consistent.
Measuring resting metabolic rate directly, rather than estimating it from a formula, shows whether adaptation is present and how large it is. That tells you whether the intake that worked at the start has become a maintenance level.
Hormones that shift as fat is lost
Leptin, the signal from fat tissue that tells the brain energy stores are adequate, falls as fat mass falls. Lower leptin raises hunger and lowers energy expenditure. Ghrelin, the hunger hormone, tends to rise, while satiety signals such as GLP-1, PYY, and CCK tend to blunt. Together these changes raise hunger and make the same deficit harder to sustain.
Thyroid output shifts as well. Active T3 often drops during prolonged restriction and reverse T3 can rise. Chronically elevated cortisol from prolonged dieting, hard training, and poor sleep favors water retention and can hide fat loss on the scale. Testosterone in men and estradiol in women can decline in a long deficit, which affects lean mass retention and recovery.
None of this is a character flaw. These are the mechanisms by which the body defends its weight set point.
Lean mass loss and the quiet drop in expenditure
Weight lost without enough protein and resistance training includes muscle, and muscle is metabolically active tissue. Losing it lowers resting expenditure further, makes the next phase harder, and worsens body composition even when the scale looks good.
Spontaneous movement falls too. Non-exercise activity, the fidgeting, walking, and standing that happen without planning, often declines during a deficit without the person noticing. Step counts drift down, and the difference can account for several hundred calories per day.
What helps
The approaches with the strongest support address the mechanisms above rather than simply cutting intake further.
High protein intake, spread across meals, protects lean mass and increases satiety. Resistance training with progressive overload gives the body a reason to keep muscle. Both do more for a stall than another reduction in calories.
Tracking steps and holding a daily floor restores the lost spontaneous movement without adding training stress.
Structured diet breaks or maintenance phases of one to two weeks, in which intake returns to estimated maintenance, can ease hunger and fatigue. Evidence on whether they improve fat loss beyond adherence is mixed, but they are a reasonable tool when a deficit has run long.
Sleep matters more than most plans allow. In some studies, short sleep raised hunger hormones, lowered insulin sensitivity, and shifted weight loss away from fat and toward lean mass.
Reducing the depth of the deficit can work better than deepening it. A moderate deficit held longer tends to produce less adaptation and less lean mass loss than an aggressive one.
Plateaus on GLP-1 therapy
People using GLP-1 receptor agonists plateau too, and the pattern is worth understanding. In the large trials of semaglutide and tirzepatide, average weight loss climbed for roughly a year to a year and a half and then leveled off. Part of that is biology, since the body re-establishes balance at a lower weight, and part is that the drug is working against the same adaptive responses described above.
The medication lowers appetite and calorie intake, but it does not remove metabolic adaptation and it does not protect lean mass on its own. Without adequate protein and resistance training, a meaningful share of the weight lost on these drugs can be lean tissue.
Several things deserve a check before assuming the drug has stopped working: whether intake has crept up, whether protein and training have slipped, and whether sleep or stress have changed. Dose changes and any decision to adjust therapy belong with the prescribing provider, who can weigh side effects, tolerability, and the individual’s response.
Where other tools fit, and where the evidence is thin
Growth hormone peptides such as sermorelin and CJC-1295/Ipamorelin are sometimes used with the aim of preserving lean mass during a deficit, based on growth hormone’s role in body composition. The human evidence for a body composition benefit in otherwise healthy adults is limited, and results vary.
Compounds that target fat cell metabolism, such as 5-Amino 1MQ, have interesting mechanisms but are mostly supported by animal and early-stage research. These are possible complements, not substitutes for protein, training, sleep, and a sustainable deficit, and whether any of them fits a given person is a conversation for a licensed provider.
A sensible order of operations
Confirm the plateau with two to four weeks of weekly averages.
Measure body composition to see whether fat is still moving.
Check protein, resistance training, steps, and sleep.
Consider a measured resting metabolic rate and baseline bloodwork, including thyroid, cortisol, and sex hormones, to see whether physiology rather than behavior is limiting progress.
Adjust deliberately with a diet break, a smaller deficit, or a maintenance phase before pushing harder.
A plateau is information, not failure. The body is showing where its set point and its defenses sit, and the response that works is measurement first, then strategy.
This content is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before making any changes to your health regimen. For more information visit www.peakformrx.health